+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genetic Testing Market Report by Type, Technology, Application, and Region 2024-2032

  • PDF Icon

    Report

  • 142 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5633295
The global genetic testing market size reached US$ 17.7 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 43.1 Billion by 2032, exhibiting a growth rate (CAGR) of 10.4% during 2023-2032. The market is primarily driven by technological advancements, rising demand for personalized medicine among the masses, increased prevalence of genetic disorders, introduction of supportive government initiatives, and rising implication of ethical, legal, and social considerations.

Genetic Testing Market Analysis:

Market Growth and Size: The sector is seeing strong growth as the public becomes more informed and the appetite for personalized medicine increases. With advancements in testing technologies, the market is penetrating new healthcare sectors at an extremely rapid pace and has become one of the most dynamic segments of the healthcare industry.

Major Market Drivers: The main factors are the introduction of new technologies, the increase in the prevalence of genetic diseases and chronic conditions and the increasing of the consumer's knowledge about genetic risks. Government initiatives and funding of genetic research also greatly assist the industry in market growth, which provide an accurate answer to how big is the genetic testing market.

Technological Advancements: Innovations in NGS (next-generation sequencing) and CRISPR technologies have revolutionized testing providing precise and budget-friendly methods. These developments have enlarged the range and opportunity of genetic testing, which in turn has increased the usage of it both in clinical settings and in research.

Industry Applications: The application of the testing includes cancer diagnosis, genetic disease diagnosis, and cardiovascular disease diagnosis. It can be used for diagnosing and managing genetic diseases makes it an inseparable part of modern healthcare.

Key Market Trends: There is a rising preference for direct-to-consumer services, in which users can acquire genetic information without using an intervening doctor. The market is also experiencing a trend where testing is becoming part of regular healthcare practices for disease screening and management, which indicates a positive outlook for the future of genetic testing market.

Geographical Trends: North America dominates the market, followed by Europe and the Asia Pacific. Factors including healthcare facilities, per capita medical expenditure, and governmental assistance also contribute to the development of these regions. Emerging markets in Latin America and the Middle East and Africa show potential for growth despite current challenges.

Competitive Landscape: The market is highly competitive with key players engaging in research and development, strategic partnerships, and regulatory compliance. These companies are focusing on expanding their testing portfolios and exploring new market opportunities to maintain their competitive edge.

Challenges and Opportunities: While the market offers substantial growth opportunities, it faces challenges such as ethical and legal implications of testing, the need for skilled professionals, and public perception issues. Addressing these challenges and harnessing technological advancements present significant opportunities for market expansion and innovation.

Genetic Testing Market Trends:

Advancements in genetic testing technologies

Advancements in genetic testing technologies have been instrumental in driving the genetic testing market size. These technological innovations have led to more accurate, efficient, and cost-effective genetic analysis methods, expanding the scope of testing into areas such as oncology, pharmacogenomics, and predictive testing, further driving the genetic testing market growth. Enhanced sequencing techniques, such as next-generation sequencing (NGS), provide detailed insights into genetic disorders, enabling early detection and personalized treatment plans. For instance,
A study on 1914 women revealed cfDNA testing significantly reduces false positives for trisomies 21 and 18 compared to standard screening, with a 100% success rate in detecting aneuploidies and higher predictive values. Furthermore, simplified processes have increased the adoption of genetic testing across various healthcare settings, contributing to the genetic testing market demand.

Increasing awareness and demand for personalized medicine

Increasing awareness and demand for personalized medicine have also played a significant role in shaping the genetic testing market outlook. Personalized medicine, which relies on genetic information to tailor treatments, has heightened the demand for genetic tests. This demand is particularly evident in sectors such as oncology and reproductive health, where genetic testing guides therapy decisions and assesses genetic disorder risks in offspring. For example, according to a study, survey with a 36% response rate showed that 83% of the 312 respondents had minimal inquiries about direct-to-consumer genetic testing, 14% dealt with result interpretation, and over 50% supported the role of genetic counsellors and clinical settings for genetic testing, with 70% open to considering it for patients with privacy, anonymity, or access concerns. Additionally, growing consumer interest in understanding genetic predispositions to health conditions further fuels genetic testing market overview, driving genetic testing market statistics and genetic testing market trends.

Rise in genetic disorders and chronic diseases

The rise in genetic disorders and chronic diseases globally is further escalating the genetic testing market statistics. Genetic testing plays a vital role in the early detection, diagnosis, and management of various conditions such as cystic fibrosis, sickle cell anemia, and Huntington’s disease. Moreover, with the increasing incidence of chronic diseases, including cancer, cardiovascular diseases, and diabetes, there is a heightened need for testing to identify genetic mutations predisposing individuals to these conditions. The World Health Organization (WHO) reports that non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, and diabetes, are responsible for 73% of global deaths annually. Genetic testing can help identify individuals at risk for these conditions. Early detection through testing improves patient outcomes, further propels the genetic testing market. The genetic testing market is substantial, with a considerable growth in the number of genetic testing per year in USA and other developed countries. Looking ahead, the future of genetic testing is promising, with continued technological advancements expected to enhance accuracy and accessibility. Genetic testing in pregnancy is also becoming increasingly prevalent, providing valuable insights into fetal health and genetic conditions.

Genetic Testing Industry Segmentation:

The report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, technology, and application.

Breakup by Type:

Predictive and Presymptomatic Testing
Carrier Testing
Prenatal and Newborn Testing
Diagnostic Testing
Pharmacogenomic Testing
Others

Diagnostic testing accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and others. According to the report, diagnostic testing represented the largest segment.

The largest sector of the market is the diagnostic testing market, which is employed to reveal or confirm specific inherited disease in symptomatic people. This sector is on the rise due to its contribution to a precise diagnosis, which is necessary for appropriate treatment and control of a plethora of genetic conditions. The fact of its broad fields of using from rare genetical diseases till common conditions brings attention to this issue in medical sector. An investigation that appeared in the Journal of Molecular Diagnostics revealed that the percentage of medical professionals who had integrated genetic diagnostic testing for hereditary cancers definitely had grown from 19.8% in 2014 to 38.4% in 2018.

Breakup by Technology:

Cytogenetic Testing and Chromosome Analysis
Biochemical Testing
Molecular Testing
DNA Sequencing
Others

Molecular testing holds the largest share in the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes cytogenetic testing and chromosome analysis, biochemical testing, and molecular testing (DNA sequencing, and others). According to the report, molecular testing accounted for the largest market share.

Molecular testing represents the largest section in the market. The methodology portion cover PCR, NGS, and other filtered DNA related analysis terms. It is very practical as it can be applied for many sections, from detecting genetic changes that give rise to diseases, to exploring cancer genetics for the reason of targeted treatments, and to unearthing genetic predispositions for different conditions. The unique capability of molecular testing associated with the precision it offers has established the field of genetic diagnostics, individualized medicine, and research as a key area in molecular science, giving it a leading position in this field. A 2021 study evaluated various COVID-19 molecular tests, revealing a high sensitivity rate of 95.9% for minimizing false negatives, and a specificity rate of 97.2% to reduce false positives. Besides, cytogenetic testing, including chromosome analysis means looking through section of chromosome in attempted to get information about chromosomal abnormalities of the patient. This part has a vital role in recognition the chromosome count, missing only one chromosome could cause genetic disorders such as Down syndrome, Klinefelter syndrome or Turner syndrome. It is widely use in pre-natal testing, cancer diagnosis and also for studying cells chromosome change, which are hardly beyond disease.

The biochemical testing, on the other hand, is directed towards the measurement of the exact amount of activity in most cases of specific enzymes in the body or the levels of proteins, hormones and other substances that comprise the body. This segment is a vital step in identifying metabolic disorders that result from enzyme deficiency by determining conditions like PKU or Tay- Sachs Disease, as possible causes.

Breakup by Application:

Cancer Diagnosis
Genetic Disease Diagnosis
Cardiovascular Disease Diagnosis
Others

Genetic disease diagnosis represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others. According to the report, genetic disease diagnosis represented the largest segment.

Genetic testing is currently utilized to diagnose a large number of diseases that are affected by both single-gene and multiple-gene factors. Genetic disease diagnosis is essential for the early detection of diseases and prompt intervention that finally aid in the condition's management. This growth is powered by its rear-rooted importance in the field of medicine which is represented in the accurate diagnoses of the genetic diseases not only for treatment but also for family planning. Between 2012 and 2022, the US led in the expansion of genetic tests, primarily for clinical diagnosis, highlighting the need for mandatory reporting and international collaboration for a comprehensive understanding of global genetic testing.

Using genetic analysis for cancer diagnosis implies finding out genetic mutations or alterations which cause cancer to develop. This portion is very vital for early tumor detection, diagnosis and controlling different categories of cancer.

Moreover, the genetic diagnosis of cardiovascular diseases involves locating these genetic variants to establish an increased risk for such heart-related defects as congenital heart defects, various cardiomyopathies, and arrhythmias.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America leads the market, accounting for the largest genetic testing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is the largest segment in the world market, driven by the world class healthcare infrastructure, the high amount of money that is spent on the healthcare sector and the presence of top companies and research institutions. The region is propelled by strong private investment, in the field of personalized medicine, large investments by governments in gene research, and favorable policy decisions from the national government. Besides, genetic disorders as well as chronic diseases, with a growing number of patients and informed population ready to access testing services, boost propel this company’s leading position in the market.

The European region remains of crucial importance in terms of the market structure which is based on well-developed healthcare systems and governmental financial support of genetic research. The locale's market growth is propelled by the growing awareness about genetic DNA, personalized medicine, and the availability of qualified personnel in the field of genetics.

The Asia Pacific region is experiencing a growing market come from the fact that it is a large population base, infrastructure on healthcare rising and increasing the expenditure on healthcare. The market also draws support from genetic disease awareness growth, personalized medicine demanded growth, and government initiatives in health care reform.

The Latin American market is developing steadily, it is stimulated by improvement of the healthcare infrastructure, by the growth of the wages, and by the increase in public health awareness. As region is faced with the increasing demand for testing services for diseases prevention, diagnosis, and treatment.

The middle east and Africa market holds a lot of promise of significant growth. Factors that include the rising number of healthcare expenditure, the growing prevalence of genetic diseases, as well as the heightened level of awareness of the significant effects of genetic testing across the industry are the major drivers of genetic testing in this part of the world.

Leading Key Players in the Genetic Testing Industry:

Market’s key players adopt different strategies to achieve fundamental objective of strengthening their market share. This include is investing heavily in research and development to innovation and evolution of genetic testing technologies, especially in the direction of next-generation sequencing (NGS) and CRISPR. They also engage in the establishment of partnerships and collaboration with other biotech companies, academic institutions, as well as healthcare providers to help them grow in their services portfolio and geographical reach. Besides this, manufacturers are making efforts to get the new devices approved by the regulator agencies to be in compliance with regulations and guarantee the patient safety. Additionally, direct-to-consumer services have been developed with the aim of leveraging consumers’ growing demand for personalized healthcare and genetic wellness.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

23andme Inc.

Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
Bio-RAD Laboratories Inc.

Cepheid (Danaher Corporation)
Eurofins Scientific
Illumina Inc.

Invitae Corporation
Luminex Corporation (DiaSorin)
Myriad Genetics Inc.

QIAGEN
Quest Diagnostics
Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

11 July 2023: Quest Diagnostics launched Consumer-Initiated Genetic Test on questhealth.com to Deliver Personalized, Actionable Health Risk Insights. The new offering helps people understand their potential risk of developing certain inheritable health conditions, with advanced technology and end-to-end support that includes personalized health reports and access to genetic counseling.

14 April 2023: QIAGEN launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

10 March 2022: Thermo Fisher Scientific introduced latest generation of SeqStudio Flex Series Genetic Analyzer to enable customer’s cutting-edge research in areas such as gene editing and infectious disease.

Key Questions Answered in This Report

1. How big is the global genetic testing market?
2. What is the expected growth rate of the global genetic testing market during 2024-2032?
3. What are the key factors driving the global genetic testing market?
4. What has been the impact of COVID-19 on the global genetic testing market?
5. What is the breakup of the global genetic testing market based on the type?
6. What is the breakup of the global genetic testing market based on the technology?
7. What is the breakup of the global genetic testing market based on the application?
8. What are the key regions in the global genetic testing market?
9. Who are the key players/companies in the global genetic testing market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genetic Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Predictive and Presymptomatic Testing
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Carrier Testing
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Prenatal and Newborn Testing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Diagnostic Testing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Pharmacogenomic Testing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Technology
7.1 Cytogenetic Testing and Chromosome Analysis
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biochemical Testing
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Molecular Testing
7.3.1 Market Trends
7.3.2 Key Segments
7.3.2.1 DNA Sequencing
7.3.2.1 Others
7.3.3 Market Forecast
8 Market Breakup by Application
8.1 Cancer Diagnosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Genetic Disease Diagnosis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Disease Diagnosis
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 23andme Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cepheid (Danaher Corporation)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Eurofins Scientific
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Illumina Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Invitae Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Luminex Corporation (DiaSorin)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Myriad Genetics Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 QIAGEN
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Quest Diagnostics
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Genetic Testing Market: Major Drivers and Challenges
Figure 2: Global: Genetic Testing Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Genetic Testing Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Genetic Testing Market: Breakup by Type (in %), 2023
Figure 5: Global: Genetic Testing Market: Breakup by Technology (in %), 2023
Figure 6: Global: Genetic Testing Market: Breakup by Application (in %), 2023
Figure 7: Global: Genetic Testing Market: Breakup by Region (in %), 2023
Figure 8: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Genetic Testing (Carrier Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Genetic Testing (Carrier Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Genetic Testing (Prenatal and Newborn Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Genetic Testing (Prenatal and Newborn Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Genetic Testing (Diagnostic Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Genetic Testing (Diagnostic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Genetic Testing (Pharmacogenomic Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Genetic Testing (Pharmacogenomic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Genetic Testing (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Genetic Testing (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Genetic Testing (Biochemical Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Genetic Testing (Biochemical Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Genetic Testing (Molecular Testing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Genetic Testing (Molecular Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Genetic Testing (Cancer Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Genetic Testing (Cancer Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Genetic Testing (Genetic Disease Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Genetic Testing (Genetic Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Genetic Testing (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Genetic Testing (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: North America: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: North America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: United States: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: United States: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Canada: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Canada: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Asia-Pacific: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Asia-Pacific: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: China: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: China: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Japan: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Japan: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: India: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: India: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: South Korea: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: South Korea: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Australia: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Australia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Indonesia: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Indonesia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Others: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Europe: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Europe: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Germany: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Germany: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: France: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: France: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United Kingdom: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United Kingdom: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Italy: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Italy: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Spain: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Russia: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Russia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Latin America: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Latin America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Brazil: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Brazil: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Mexico: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Mexico: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Middle East and Africa: Genetic Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Middle East and Africa: Genetic Testing Market: Breakup by Country (in %), 2023
Figure 82: Middle East and Africa: Genetic Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Global: Genetic Testing Industry: SWOT Analysis
Figure 84: Global: Genetic Testing Industry: Value Chain Analysis
Figure 85: Global: Genetic Testing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Genetic Testing Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Genetic Testing Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Genetic Testing Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Genetic Testing Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Genetic Testing Market: Competitive Structure
Table 7: Global: Genetic Testing Market: Key Players

Companies Mentioned

  • 23andme Inc.
  • Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
  • Bio-RAD Laboratories Inc.
  • Cepheid (Danaher Corporation)
  • Eurofins Scientific
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation (DiaSorin)
  • Myriad Genetics Inc.
  • QIAGEN
  • Quest Diagnostics
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...

Table Information